Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Auricle
AddedMar 22, 2024
UpdatedJul 1, 2026
Auricle

Auricle

Seed

Auricle: Innovating neurostimulation implants to restore hearing, less invasive than cochlear implants.

HQ
San Francisco, CA, US
Founded
2020
Accelerator
Y Combinator logoY CombinatorW21
Overview
Compare
Fundraising
Employees
Website

Auricle is a medical device company focused on developing a breakthrough neurostimulation implant designed to restore hearing in patients who no longer benefit from hearing aids but are not ready for cochlear implants. The company's innovative approach aims to preserve remaining natural hearing through a reversible and less invasive surgery, addressing key patient concerns associated with cochlear implants. Auricle's mission is to provide an effective alternative for millions of patients worldwide.

Founded out of Stanford Biodesign, Auricle has garnered support from prominent organizations such as Y Combinator, StartX, and Fogarty Innovation. These affiliations have helped the company make significant strides in its mission to revolutionize hearing restoration. Auricle's impact is underscored by its commitment to improving the quality of life for individuals with hearing impairments through cutting-edge technology and patient-centered solutions.

Auricle - Similar Companies

AudioFocus logo

AudioFocus

audiofocus.io

Audicus logo

Audicus

audicus.com

Qualia Oto logo

Qualia Oto

qualiaoto.com

Cochlear logo

Cochlear

cochlear.com

PionEar Technologies logo

PionEar Technologies

pionear-tech.com

Realeve logo

Realeve

Soundwave Hearing logo

Soundwave Hearing

hearsoundwave.com

Attune Neurosciences logo

Attune Neurosciences

attuneneuro.com

Hearing Health Science logo

Hearing Health Science

soundbites.com

Epic Neuro logo

Epic Neuro

Oto logo

Oto

joinoto.com

Otolith Sound logo

Otolith Sound

otolithlabs.com

Scion Neurostim logo

Scion Neurostim

scionneurostim.com

Sonitus Medical logo

Sonitus Medical

sonitusmedical.com

Concha Labs logo

Concha Labs

conchalabs.com

Auricle - Quick Facts

Who are Auricle's competitors?

Companies similar to Auricle include AudioFocus, Audicus, Qualia Oto and Cochlear.

When was Auricle founded?

Auricle was founded in 2020.

Where is Auricle's headquarters located?

Auricle's headquarters is located in San Francisco, CA, US.

When was Auricle's last funding round?

Auricle's most recent funding round was for $125k (USD) in March 2021.

How much has Auricle raised to-date?

As of Mar 22, 2021, Auricle has raised a total of $125k (USD).

How many employees does Auricle have?

Auricle has 5 employees as of Feb 24, 2024.

Auricle - Classification

Ownership
  • Venture Capital
Technology
  • Neurostimulation
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified